Table 1.

Blood/Lymph Ratio of FITC+ Blood Lymphocytes Versus CM-Dil+ Lymph Lymphocytes

Experiment Lymph Source Days-150N-151Ratio Blood/Lymph
Blood LymphosLymph Lymphos
1  Subcutaneous pseudoafferent  10.7  2.92 ± 0.03  ND  
2  Subcutaneous pseudoafferent  6.5  3  2.51 ± 0.17  ND  
Subcutaneous efferent  8.4  8  1.96 ± 0.13 ND  
4  Subcutaneous efferent  2.8  2.90 ± 0.18  0.64 ± 0.09  
5  Mesenteric efferent 4.0  3  6.55 ± 1.19  0.52 ± 0.02  
Mesenteric efferent  6.6  5  3.87 ± 0.11 0.27 ± 0.02  
7  Mesenteric efferent  5.5 3  3.80 ± 0.92  0.60 ± 0.20 
    3.50 ± 0.57-152 0.51 ± 0.08-152 
Experiment Lymph Source Days-150N-151Ratio Blood/Lymph
Blood LymphosLymph Lymphos
1  Subcutaneous pseudoafferent  10.7  2.92 ± 0.03  ND  
2  Subcutaneous pseudoafferent  6.5  3  2.51 ± 0.17  ND  
Subcutaneous efferent  8.4  8  1.96 ± 0.13 ND  
4  Subcutaneous efferent  2.8  2.90 ± 0.18  0.64 ± 0.09  
5  Mesenteric efferent 4.0  3  6.55 ± 1.19  0.52 ± 0.02  
Mesenteric efferent  6.6  5  3.87 ± 0.11 0.27 ± 0.02  
7  Mesenteric efferent  5.5 3  3.80 ± 0.92  0.60 ± 0.20 
    3.50 ± 0.57-152 0.51 ± 0.08-152 

Abbreviation: ND, not determined.

F0-150

Experiments were continued until the lymphatic cannulae were occluded or dislodged.

F0-151

Indicates the number of paired blood and lymph samples obtained during each experiment.

F0-152

Mean ± SEM.

or Create an Account

Close Modal
Close Modal